Risk Reduction Top Driver for Biopharmaceutical Raw Material Development
Changes and Challenges for Generic Drugs
Relationship-building at Top of Mind for Clients
Complying with Revised Weighing Guidelines
Pharma Investments Reflect Key Industry Trends
Comparing Manufacturing Process Options
Implementing Supply-Chain Security
Bioavailability Enhancement with Lipid-Based Drug-Delivery Systems
Pharmaceutical Technology, August 2014 Issue (PDF)